Clinical Trial

Study of the Antibiotic-resistance Profile of Enterobacterales Isolated From Rectal Mucosal Buffer of PrEP Subjects

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2026 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
The importance of the study lies mainly in expanding knowledge of the phenomenon of antibiotic resistance in subjects using PrEP, studying for the first time in this population the resistance phenotype in commensal Enterobacterales of the gastrointestinal tract. The data obtained from this study could pave the way for potential surveillance and awareness programs for the critical and conscious use of antimicrobials in PrEP subjects in order to mitigate the problem of antibiotic resistance, which currently represents a real global challenge.
Trial Details
NCT Number NCT07370948
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Infection
Enrollment 200 participants
Start Date 2025-05-30
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-01-27